Delivery Order SPE2DB22D1017-SPE2DB25FG9UV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,187.56 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (quantity 60) on August 13, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Calquence is a pharmaceutical product used in the treatment of hematologic...
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count package) on July 28, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Calquence is a prescription oncology medication used in the treatment of certain blood cancers,...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract, which is expected to be completed by August 11, 2025, is non-set-aside and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,187.56 for Calquence 100 mg tablets (60-count units) on August 11, 2025, with completion targeted for September 2, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for 60 tablets of Calquence 100 mg on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, non-competitive set-aside delivery order was fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. As a child contract, this award is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Calquence 100 mg tablets (60 count) with a ceiling value of $5,593.77. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order is scheduled for completion by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Calquence 100 mg tablets (60-unit quantity) under a firm fixed-price contract with a ceiling value of $5,593.77. This non-set-aside delivery order is scheduled for completion by September 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a $22,375.12 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Calquence 100 mg, with performance to be completed by September 9, 2025. This contract award employs firm fixed price terms and carries no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,593.77 on August 1, 2025, for the supply of Calquence 100 mg tablets (60 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 22, 2025, and performance to be fulfilled at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's broader relationship with DLA, leveraging the company's...
- The Defense Logistics Agency awarded a $5,593.77 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Calquence 100 mg tablets (60-count units). This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9UVDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,593.77 for 60 tablets of Calquence 100 mg on August 14, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Calquence is a prescription medication used in oncology treatment, reflecting the Defense Logistics Agency's role in supplying critical pharmaceutical products to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical commodities globally. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to meet competitive procurement requirements and serve as a critical pharmaceutical distributor for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 8/14/25 |